The South African Health Products Regulatory Authority has welcomed the US lifting of the suspension of the Johnson & Johnson vaccine.
The jab was suspended last week as a precautionary measure because of rare cases of blood clots.
SAHPRA says it will be monitoring developments.
Meanwhile, Health Minister Zweli Mkhize is expected to make an announcement on when the Sisonke trial will commence in South Africa.
More Stories
Theft And Vandalism Hampering Operations – Eskom
Gauteng Promises Better Roads
Ramaphosa To Answer Scopa Questions On Funding
NICD Reports 4 100 New COVID-19 Cases In SA
Independent Advocate Appointed To Probe Fritz Claims
Oldest District Six Claimant Dies Before Returning Home
IPID Lays Charges Against Police Boss Sitole
NICD Reports 4 514 New COVID-19 Cases
Scopa Looks Into Alleged Use Of Public Funds For ANC Activities
386 People Referred For Prosecution For COVID Tender Fraud – SIU
Families Of Trapped Lily Mine Workers Feel Betrayed By Government
NICD Reports 3 197 New COVID-19 Cases